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Abstract 
Background: Depression is common comorbidity in patients with coronary artery disease 
(CAD), which often remain undetected and untreated. Objective: This study aimed to 
examine the psychometric properties of the Depression Module of the Patient Health 
Questionnaire (PHQ-9) on a sample of cardiac patients in Iran. Method: The Persian version 
of the PHQ-9 was developed and administered to 150 patients with a diagnosis of coronary 
artery disease (CAD), admitted to a tertiary hospital in Tehran, Iran. The major depression 
module of the International Neuropsychiatric Interview (MINI) was applied as the gold 
standard. Results: Cronbach's alpha for the total PHQ-9 was 0.80. The optimal cut-off score 
of ≥7 showed a sensitivity of 76, specificity of 78 and the area under curve of 0.82. 
Conclusion: The Persian version of the PHQ-9 has acceptable psychometric properties to 
screen and detect a current depressive episode in patients with CAD, with recommended cut-
off score of ≥7.  
Keywords: nursing, coronary artery disease, the PHQ-9, depression, validation study 
 
Impact statement  
Cardiovascular disease is a global health concern. The comorbidity of depression adds 
significantly to the disease burden increasing the risk of future cardiac events and mortality. 
By cross cultural validation of the PHQ-9, the recommended tool by the American Heart 
Association, this study facilitates screening and treatment of depression in Persian patients 
with coronary artery disease.   
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Introduction 
Studies from around the world suggest that between 10% and 50% of patients with cardiac 
disease experience depression (Lichtman et al., 2008). A considerable number of cardiac 
diseases in Iran are affected by depression comorbidity, with the reported prevalence rate 
ranging between 42% and 49% (Bayani et al., 2011; Moradyan, Ebadi, Saeid, & Asiabi, 
2013). There is substantial evidence linking depression with increased risk of incident 
coronary artery disease (CAD) as well as poorer disease prognosis (Lichtman et al., 2008). 
Despite the high prevalence, adverse patients and disease outcomes and yet cost effective 
treatability, depression in cardiac patients continues to remain under-recognized and under-
treated (Ramamurthy, Trejo, & Faraone, 2013). 
In 2008, the American Heart Association’s advisory committee (AHA) recommended 
that all patients with a diagnosis of cardiovascular disease be routinely screened for 
depression and treated as necessary (Lichtman et al., 2008). Although, this recommendation 
has been criticized for being premature due to lack of strong evidence to support the 
usefulness of depression screening in cardiac patients (Hasnain, Vieweg, Lesnefsky, & 
Pandurangi, 2011; Ziegelstein, Thombs, Coyne, & de Jonge, 2009), this enterprise has 
certainly risen awareness towards depression in cardiac patients and has stimulated research 
on the topic (Beach et al., 2013; Haddad et al., 2013; Holmes, 2011). The results of a recent 
meta-analysis study suggest that mental health treatments including antidepressants and 
psychotherapies reduce the risk of recurrent cardiac events and improve depression 
symptoms in patients with cardiac disease, with no effect on mortality (Rutledge, Redwine, 
Linke, & Mills, 2013). It is also known that depression screening in combination with a 
collaborative care intervention, such as referral to mental health services, improve depression 
symptoms, quality of care and adherence to treatment regimen in patients with cardiac 
diseases (Colquhoun et al., 2013; Thombs, Ziegelstein, & Whooley, 2008). These findings 
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provide additional evidence to support screening and appropriate treatment of depression in 
cardiac patients. 
The Patient Health Questionnaire-9 (PHQ-9) and Patient Health Questionnaire-2 
(PHQ-2) have been shown to be useful tools for screening depression (Kendrick & Little, 
2013; Kroenke, Spitzer, & Williams, 2001, 2003; Lowe, Kroenke, & Grafe, 2005; Rooney et 
al., 2013). The PHQ-2 consists of the first two items of the PHQ-9. The AHA advocates a 
two-step screening approach that uses the PHQ-2 and the PHQ-9. The screening procedure 
starts with the first two questions of the PHQ-9, i.e., the PHQ-2, and continues with the 
remaining seven PHQ-items if the patient’s response to one or both of the first two questions 
is positive (Kroenke et al., 2003). Patients screened positive on the PHQ-9 should be referred 
to an appropriate mental health provider for further assessment and/or treatment (Colquhoun 
et al., 2013; Lichtman et al., 2008). The validity of the PHQ-9 is well established in primary 
care (Cameron et al., 2011; Cameron, Crawford, Lawton, & Reid, 2008; Gilbody, Richards, 
& Barkham, 2007). Although early validation studies support the use of the tool in patients 
with cardiac disease (Haddad et al., 2013; McManus, Pipkin, & Whooley, 2005; Stafford, 
Berk, & Jackson, 2007), the usefulness of the PHQ-09 as an screening tool for cardiac 
patients, particularly patients from culturally and linguistically diverse backgrounds needs 
further investigation. McManus et al. (2005) established the validity of the PHQ-9 on 1,024 
outpatients with CAD in the United States using the Clinical Interview Schedule (CIS) as 
criterion. Similarly, Stafford et al. (2007) compared the psychometric characteristic of the 
PHQ-9 with the Hospital Anxiety and Depression Scale (HADS) on a sample of recently 
hospitalized cardiac patients in Australia and used the MINI as the criterion standard. Both 
studies found that the PHQ-9 had acceptable properties for screening depression in the target 
population. In addition, Haddad et al. (2013) found that the PHQ-9 was superior to the 
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Hospital Anxiety and Depression Scale (the HADS) in detecting depression in cardiac 
patients in primary care settings (Haddad et al., 2013).  
Previous research also confirms the short term and long-term prognostic value of the 
PHQ-9. Beach et al. (2013) found that each additional point on the PHQ-9 increased the risk 
of readmission for a cardiac related reason over the subsequent 6 months by 9% (Beach et al., 
2013). In another study, patients with higher the PHQ-9 scores at baseline experienced 
greater adverse events post percutaneous coronary intervention at 1.5 year- follow up 
(Pedersen et al., 2009). Also, patients who were screened positive on the PHQ-9 showed 41% 
greater risk for adverse cardiovascular outcomes in long term follow ups (Elderon, 
Smolderen, Na, & Whooley, 2011). Although the available evidence are promising, the 
sensitivity and specificity of the PHQ-9 to accurately screen, detect and monitor depression, 
and its prognostic value in cardiac patients from linguistically and culturally diverse 
backgrounds need further research.  
This study aimed to validate the psychometric properties of the PHQ-9 to screen 
depression in a sample of cardiac patients from Iran. Considering the high prevalence rate of 
depression in Iranian patients, there is a need for a brief, valid and user-friendly tool to assist 
clinicians with screening for this comorbidity in the target population. Additionally, the study 
investigated the diagnostic value of the PHQ-9 using the receiver operating characteristic 
curve (ROC). In a ROC curve, the true positive rate (sensitivity) is plotted in function of the 
false positive rate (100-Specificity) for different cut-off points of a parameter (Hajian-Tilaki, 
2013). 
Method 
Participants and Procedures 
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Using consecutive sampling, 170 patients with a diagnosis of CAD were invited to this 
prospective study and those interested in the study were screened against the study inclusion 
and exclusion criteria. Patients with a diagnosis of CAD including acute coronary syndrome 
(unstable angina and myocardial infarction) and patients who had been admitted for a 
coronary artery bypass graft surgery (CABG), aged 20 years or above, were recruited from a 
tertiary hospital in Tehran. The recruitment took place from March 2012 to June 2012. 
Patients who, according to their medical records, were suffering from any brain injury, 
dementia, mental illnesses other than depression or had terminal illness were excluded. Out 
of the 170 recruited participants, 20 patients were inaccessible for the subsequent MINI 
interview, and they were excluded from the study. The study received ethical approval from a 
relevant human research ethics committee, the objectives of the study were explained to 
participants and informed consents obtained. Participants were asked to complete the Persian 
versions of the PHQ-9 while they were in hospital. Translation and back-translation of the 
PHQ-9 and the MINI were conducted following an approved guideline (Guillemin, 
Bombardier, & Beaton, 1993). The Persian versions of translated tools were then reviewed by 
five psychologists/psychiatrists for clarity. Some participants (31%) were unable to complete 
the questions themselves because of limited literacy or vision- related issues. In these 
circumstances, the researcher read out the questions to participants and wrote down their 
responses.   
Measures 
Socio-Demographic and Clinical Data 
The following socio-demographic and clinical data were recorded for all patients: age, sex, 
education, comorbidities, reason for hospital admission, time since first diagnosis of cardiac 
disease, antidepressant medication and history of psychiatric disease other than depression.   
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The MINI: Major Depressive Episode Module 
The depression module of the Mini Neuropsychiatric Interview (MINI) was used as the gold 
standard diagnostic tool for depression in this study. The MINI is the most widely used, brief 
and structured interview to assess the major Axis I psychiatric disorders in DSM-IV and ICD-
10. The MINI demonstrates high validity and reliability scores when compared with the 
Structured Clinical Interview for DSM-III-R (the SCID-P) and the International 
Classification of Diseases (ICD-10) (Kittirattanapaiboon P & M., 2005; Sheehan et al., 2006). 
The Major Depressive Episode Module is consisted of maximum 9 questions, assessing 
depression symptoms over the past two weeks. If the answer to the first two questions is 
‘No’, the interview is ended and the participant identified as not having a major depressive 
episode. If the answer to the either or both questions is ‘Yes’, then the interviewer will 
proceed with the following 7 questions. A score 5 or more on the 9 questions indicates a 
current major depressive episode (Sheehan et al., 2006). The MINI has not been validated in 
an Iranian sample, but been used as the gold standard for validation of another depression 
assessment tool in this population (Ahmadpanah et al., 2016). The administration of the 
interview requires no professional training, and the interview can be completed in short time. 
In the current study, participants were interviewed by a trained clinician, who was blind to 
the patient’s PHQ-9 results, via telephone within one week of completion of the PHQ-9. 
The Patient Health Questionnaire (PHQ-9)  
The PHQ-9 is a 9-item instrument which assesses depression symptoms over the past two 
weeks. Response to each item can range from 0= not at all to 3= nearly every day. Total 
scores on the PHQ-9 can range from 0- 27 (Kroenke et al., 2001). In the original reference 
population, a threshold score of 10 or higher, 15 or higher and 20 or higher indicated mild 
depression, moderate to major depression and severe major depression respectively. In some 
settings, a threshold score of 15 or more is recommended for initiating treatment with 
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antidepressants (Arroll et al., 2010). The PHQ-2 consists of the first two questions of PHQ-9, 
enquiring about the frequency of depressed mood and anhedonia over the past two weeks 
(Kroenke et al., 2003). Total scores, in the PHQ-2, range from 0- 6. In the original reference 
population, a cut off of 3 or higher was considered positive screening for major depression.  
The PHQ-9 is the depression component of the Patient Health Questionnaire which has been 
developed based on the diagnostic criteria for major depressive disorder in the Diagnostic and 
Statistical Manual Fourth Edition (DSM-IV). The PHQ-9 has many of the characteristics of a 
good screening tool; it is brief, simple and readily accessible. This self-report tool can assist a 
busy clinician to easily screen, diagnose, monitor and measure the severity of depression 
(Kroenke et al., 2001).  
A systematic review of evidence on the psychometric and pragmatic characteristics of 
the PHQ-9 revealed that the tool possesses good psychometric properties for detecting and 
monitoring depression in primary care as well as medical specialty populations (Kroenke, 
Spitzer, Williams, & Lowe, 2010). The initial validation study, conducted on a sample of 
primary care and obstetrics-gynaecology patients, showed that the tool had good performance 
in detecting patients with major depression (sensitivity of 88%) and ruling out those without 
major depression (specificity of 88%), using the PHQ-9 cut-off score of ≥10 (Kroenke et al., 
2001). In the United Kingdom primary care setting, the optimum cut-off point was 
established against the Structured Clinical Interview for DSM (SCID), with a reported 
sensitivity of 91.7% and specificity of 78.3% (Gilbody et al., 2007). The PHQ-9 has also 
been successfully validated in a sample of patients from diverse cultural backgrounds 
including African American, Chinese American, Latino and non-Hispanic white in the United 
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The Statistical Package for the Social Science 21 (SPSS 21) was used for analysing the data.  
The internal consistency of the PHQ-9 was measured by Cronbach's alpha coefficient, and the 
criterion validity of the tool assessed using the MINI: Major Depressive Episode Module. 
The sensitivity, specificity, predictive values and likelihood ratios were calculated for various 
cut-off values, ROC curve was constructed and the area under the curve (AUC) calculated to 
determine the best cut-off score for the Persian version of the PHQ-9.  
Results 
Overall 150 inpatients with a diagnosis of CAD, predominantly male (69%), married (91%) 
and with at least primary school education (73%) completed the study. Mean age of 
participants was 61.48±9.01 years. Median time from the first diagnosis of a cardiac 
condition was 20.5 months, with interquartile range of 46 months. Reasons for hospital 
admission included medicine therapy, angioplasty, angiography and coronary artery bypass 
graft (CABG). The demographics and clinical characteristics of participants are presented in 
Table 1.  
[Insert Table 1 here] 
 
The mean PHQ-9 score was 6.16 (SD = 6.28), scores ranged from 0 to 27, with the median 
score of 4.0 and a skewness of 1.19 (SD = 0.19). The depression status of participants is 
summarized in Table 2.  
[Insert Table 2 here] 
 
Reliability and Item Analysis 
Cronbach's alpha for the total PHQ-9 was 0.80. The mean scores for each individual item and 
correlation of the item with the total PHQ-9 scale are shown in Table 3. Item 2: feeling tired 
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or having little energy and item 3: trouble falling or staying asleep, or sleeping too much 
were the two most commonly endorsed items, while item 9: thoughts that you would be better 
off dead, or of hurting yourself was the least commonly endorsed item. All items contributed 
to the internal consistency of the scale, except for item 9, which did not affect the Cronbach's 
alpha for the total PHQ-9, when the item was removed.  
[Insert Table 3 here] 
Criterion Validity Analysis   
The criterion validity of the PHQ-9 was investigated in relation to the Persian version of the 
MINI: Major Depressive Episode Module. Using the MINI, 33 (22%) participants met the 
diagnostic criteria for major depression. Using the cut off of ≥7 for diagnosis of major 
depression, the PHQ-9 had a sensitivity of 76 and specificity of 77, positive predictive value 
of 48.0, negative predictive value of 91.8, positive likelihood ratio of 3.2 and negative 
likelihood ratio of 0.3. Table 4 demonstrates the sensitivity, specificity and the predictive 
values for different PHQ-9 cut offs in diagnosing major depression.  
[Insert Table 4 here] 
The area under the curve for the Persian version of PHQ-9 was 0.8 (Figure 1).  
[Insert Figure 1 here] 
Discussion 
The aim of this study was to determine the validity of the Persian version of the PHQ-9 to 
screen and diagnose depression in cardiac patients in acute care settings. Our study 
demonstrated a high internal consistency of the Persian version of the PHQ-9 to measure 
depression in cardiac patients.  In the current study, the optimum cut-off score to detect major 
depression was established with the PHQ-9≥ 7 (sensitivity=75.7, specificity= 78.7), while the 
generally recommended cut-off of ≥ 10 reduced the sensitivity of the tool to 69.9%. In a 
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study of outpatients with CAD in the US, the cut-off score ≥10 also resulted in a low 
sensitivity (sensitivity= 54.3%, specificity= 91.1%). In this study, however, authors did not 
report the operating characteristics of the PHQ-9 when different cut-offs were applied 
(McManus et al., 2005). In a sample of patients with CAD in Australia, optimum results were 
obtained using the PHQ-9 cut-off score of ≥ 6, with the reported sensitivity of 82.9% and 
specificity of 78.7% (Stafford et al., 2007). In our study, however, the PHQ-9 cut-off score of 
≥ 6 increased the sensitivity to 82% while decreased the specificity to 73%. 
Using the CIS-R as a diagnostic standard, Haddad et al. (2013) reported the optimum 
operating characteristics with the PHQ-9 cut-point of ≥8 (sensitivity=94%; specificity=84%) 
in a sample of out-patients with CAD in the United Kingdom. Likewise, in our study, the 
PHQ-9≥ 8 decreased the sensitivity of the tool to 73%, although the specificity was improved 
(81%).   
In the current study the AUC was 0.80, suggesting that Persian version of the PHQ-9 
discriminates well between persons with and without major depression and that the tool can 
be used to detect depression in cardiac patients, although this value is lower than the AUC of 
0.88 reported by previous research (Stafford et al., 2007). We did not examine the categorical 
algorithm of the PHQ-9, as the results of previous studies suggest lower sensitivity of the tool 
to detect major depression when the categorical algorithm is applied (Haddad et al., 2013; 
Stafford et al., 2007). We found that Item 2: feeling tired or having little energy and item 3: 
trouble falling or staying asleep, or sleeping too much were the two most commonly endorsed 
items in the scale. These somatic symptoms are expected from patients with cardiac patients 
and similar findings were observed by Lotrakul et al. (2008) in a sample of out-patients with 
CAD. Whereas item 9: thoughts that you would be better off dead, or of hurting yourself was 
the least commonly endorsed item and did not contribute to the internal consistency of the 
scale. The finding is in line with other previous studies (Lotrakul, Sumrithe, & Saipanish, 
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2008; Razykov, Ziegelstein, Whooley, & Thombs, 2012), and provides further support that 
the PHQ-8 is possibly a better choice for cardiac patients.  
It is noted that in the current study, the PHQ-9 was administered while participants 
were in hospital; however, they were mainly interviewed using MINI after discharge from 
hospital. The transition from hospital setting to home setting might affect participants’ 
feelings and therefore their responses to the interview questions, although the interviewer 
explicitly pointed out that the participants should reflect on their feelings over the preceding 
two weeks.       
Conclusion:  
The Persian version of the PHQ-9 has acceptable psychometric properties for screening and 
diagnosing depression in patients with CAD, with a recommended cut-off score of ≥ 7 for 
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Table 2: Depression status of study participants according to the PHQ-9  
 
PHQ-9 scores       n (%) 
0–4 (no depression) 79 (53) 
5–9 (mild depression) 32 (21) 
10–14 (moderate depression) 19 (13) 
15–19 (moderately severe depression ) 13 (9) 
20–27 (severe depression) 
7 (5) 
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Table 3: PHQ-9 item level values and item-total correlations (n=150)  
 




1. Little interest or pleasure in doing things 
2. Feeling down, depressed or hopeless 
3. Trouble falling or staying asleep, or sleeping too much 
4. Feeling tired or having little energy 
5. Poor appetite or overeating 
6. Feeling bad about yourself or that you are a failure  
7. Trouble concentrating on things  
8. Moving or speaking so slowly that other people could 
have noticed  
9. Thoughts that you would be better off dead, or of 
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≥ 6 81.8 73.5 46.5 93.4 3.0 0.2 
≥ 7 75.7 76.9 48.0 91.8 3.2 0.3 
≥ 8 72.7 81.2 52.1 91.3 3.8 0.3 
≥ 9 69.7 82.9 53.4 90.6 4.0 0.3 
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Figure 1: The Receiver Operating Characteristics (ROC) curve of the PHQ-9 versus the MINI 
for diagnosis of major depression.  
 
 
 
